iollo Analysis
What is iollo?
iollo provides advanced blood testing, measuring over 500 biomarkers from a single sample to deliver personalized health insights and assess biological age and wellness.
Founded
2022
Revenue
$750K
Company Stage
Pre-Seed
YC Batch
S22
Product Features & Capabilities
- Measure 500+ advanced biomarkers, personalized health insights, biological age assessment, metabolic health evaluation, heart health monitoring, gut microbiome analysis, home sample collection, personalized reports and recommendations, regular health engagement, HSA/FSA accepted.
Who are the founders of iollo
DG
Daniel Gomari
Founder/CEO
Investors
- Goodwater Capital
- Y Combinator
- Palrecha Capital
- Fundament
- Hummingbird Ventures
Company Pricing
- Essential Plan: From $299 per test
- Expanded Plan: From $399 per test
- Comprehensive Plan: From $459 per test
See something that needs updating? Suggest edits to this profile.